New results are raising hopes for easing one challenge of living with HIV: the need to take daily pills for life, both to ward…
Comments closedCategory: Articles
Health care workers have been especially hard hit by the current outbreak of Ebola in the northeastern part of the Democratic Republic of the Congo…
Comments closedOne week after celebrating the end of a potentially explosive Ebola outbreak in Équateur province in the Democratic Republic of the Congo (DRC), Peter Salama…
Comments closed
Mylan, lambasted for EpiPen price hikes, complains of overpriced anti-HIV drugs in the United States
Mylan, a giant generic drugmaker headquartered in Canonsburg, Pennsylvania, that took a bashing in 2016 for steeply raising the price of its EpiPen that treats severe…
Comments closedAn experimental Ebola vaccine will likely be used again in the Democratic Republic of the Congo (DRC) to help end an outbreak. Roughly a week after…
Comments closedThe ambitious campaign to “end AIDS” by 2030 is badly off track, officials said at the International AIDS Conference here last week. Funding for efforts…
Comments closedWhen Science published a monkey study nearly 2 years ago that showed an anti-inflammatory antibody effectively cured monkeys intentionally infected with the simian form of the AIDS…
Comments closedDolutegravir, which enjoys a reputation as the best of 32 marketed antiretroviral drugs, took a serious hit in May when a preliminary analysis from a…
Comments closedAn Ebola outbreak that erupted 8 May in a remote region of the Democratic Republic of the Congo (DRC) and then threatened to explode in…
Comments closed






